Ryne Bio

Ryne Biotechnology is a San Diego, California-based company that utilizes induced pluripotent stem cell (iPSC) technology to treat neurological disorders. The company leverages iPSC technology, enabling scientists to create any human cell type to advance its off-the-shelf neuronal replacement therapy. Ryne Bio is developing a drug candidate platform, including next-generation gene modification programs, which have the potential to alter and reverse disease progression in Parkinson’s disease and other central nervous system disorders.